Cryoablation is a minimally invasive local treatment that uses extreme cold to destroy targeted tumor tissue. During the procedure, specially designed cryoablation probes are precisely positioned within or around the tumor, typically under the guidance of imaging technologies such as CT, ultrasound, or MRI.

The probes rapidly cool the surrounding tissue, creating an ice ball that encompasses the treatment area. Controlled freeze–thaw cycles cause irreversible cellular injury and can lead to the destruction of the targeted tumor tissue.

Cryoablation may be used as a local treatment for selected tumors in organs such as the kidney, liver, lung, and prostate, as well as certain bone and soft-tissue tumors. Depending on the type and stage of cancer, it may be used with curative intent, for local tumor control, or to relieve cancer-related symptoms.

Whether cryoablation is appropriate depends on several factors, including the type, size, number, and location of the tumor, its relationship to nearby organs and critical structures, the stage of the disease, previous treatments, and the patient’s overall health.

What Is Cryoablation?

Cryoablation is a form of tumor ablation therapy that uses extremely low temperatures to destroy abnormal or cancerous tissue.

During the procedure, a physician places one or more specialized cryoablation probes into or around the tumor under image guidance.

The probes use a controlled cooling process to rapidly lower the temperature of the surrounding tissue and create an ice ball.

When tissue is exposed to sufficiently low temperatures, several biological processes can occur, including intracellular ice formation, cellular dehydration, disruption of cell membranes, and damage to small blood vessels.

These effects can result in irreversible cellular injury and destruction of the targeted tissue.

Following treatment, the treated tissue may gradually be broken down and removed through the body’s natural healing processes or replaced by scar tissue.

How Does Cryoablation Work?

Cryoablation generally relies on controlled freeze–thaw cycles to produce tissue destruction.

Step 1: Imaging and Treatment Planning

CT, ultrasound, MRI, or another appropriate imaging modality is used to identify the tumor and assess its size, location, shape, and relationship to nearby organs and critical structures.

The treatment plan is designed to determine the safest and most effective position for the cryoablation probes.

Step 2: Precise Probe Placement

One or more cryoablation probes are inserted through the skin and carefully positioned within or around the target tumor.

The number and configuration of probes depend on the size and shape of the tumor.

Step 3: Rapid Freezing

The cryoablation system rapidly cools the probe tips and the surrounding tissue.

As the temperature falls, an ice ball forms around the probe.

Step 4: Monitoring the Ice Ball

The ice ball can often be visualized using imaging during the procedure.

The physician monitors its size and position to ensure that the intended treatment area adequately covers the tumor while minimizing exposure of nearby critical structures.

Step 5: Freeze–Thaw Cycles

Depending on the treatment protocol, multiple freezing and thawing cycles may be performed.

Repeated freeze–thaw cycles can increase tissue injury and contribute to the destruction of the targeted tumor cells.

Step 6: Post-Treatment Assessment

Imaging may be performed immediately after treatment or during follow-up to assess the treated area.

Regular follow-up imaging is important to evaluate the treatment response and detect any residual or recurrent disease.

How Does Cryoablation Destroy Tumor Cells?

Extreme cold can damage cells through several mechanisms.

Ice Crystal Formation

Rapid freezing can cause ice crystals to form within and around cells, disrupting cellular membranes and intracellular structures.

Cellular Dehydration

Freezing alters the movement and distribution of water and electrolytes within tissues, which can cause cellular dehydration and structural damage.

Microvascular Injury

Cryoablation can damage small blood vessels within the treatment zone, reducing blood flow to the treated tissue.

Repeated Freeze–Thaw Injury

The combination of freezing and subsequent thawing can cause additional cellular and vascular damage.

Together, these mechanisms can result in irreversible tissue injury and cell death within the treated area.

Cryoablation can also trigger local inflammatory and immune responses. Researchers are investigating whether these effects may have a role in combination with immunotherapy.

However, the immune response associated with cryoablation should not be interpreted as evidence that cryoablation alone can eliminate cancer throughout the body.

Which Cancers Can Be Treated With Cryoablation?

Cryoablation is primarily considered for selected localized tumors.

Its clinical applications may include:

Kidney Tumors

Percutaneous cryoablation is an established local treatment option for selected patients with small renal tumors.

It may be considered for patients in whom preserving kidney function is particularly important or for those who may face increased risks from conventional surgery.

The choice between cryoablation, partial nephrectomy, active surveillance, or other treatment options depends on the patient’s individual circumstances.

Liver Tumors

Cryoablation may be considered for selected liver tumors.

Other potential treatment options include surgical resection, radiofrequency ablation, microwave ablation, transarterial therapies, radiation therapy, and systemic treatment.

Treatment selection depends on factors such as tumor size, number, location, liver function, and the presence of disease elsewhere in the body.

Lung Tumors

For selected patients with early-stage or localized lung tumors, percutaneous cryoablation may be considered when surgery is not appropriate or when another local treatment approach is being evaluated.

Patient selection is particularly important because the location of a lung tumor and its proximity to blood vessels, airways, and other structures can affect both treatment feasibility and risk.

Prostate Cancer

Cryoablation may be used as a focal or whole-gland treatment in selected patients with prostate cancer.

However, prostate cancer treatment depends strongly on disease risk classification, tumor characteristics, life expectancy, and patient preferences. Cryoablation is therefore not appropriate for every patient with prostate cancer.

Bone and Soft-Tissue Tumors

In selected cases, cryoablation may be used to treat certain bone or soft-tissue tumors.

It may also be considered for some patients with painful bone metastases, where local treatment can help with pain control and local disease management.

What Are the Potential Advantages of Cryoablation?

Minimally Invasive

Cryoablation is generally performed through small percutaneous access points rather than through the larger incisions required for many conventional surgical procedures.

Visualization of the Treatment Zone

One of the distinctive features of cryoablation is that the developing ice ball can often be visualized during treatment.

This allows the physician to monitor the approximate extent of the treatment zone and adjust the procedure when necessary.

Potential for Preservation of Surrounding Tissue

The ability to visualize and control the ice ball can help physicians plan treatment around nearby anatomical structures.

In selected cases, this may help minimize injury to surrounding healthy tissue.

However, cryoablation can still damage adjacent organs or structures, particularly when the tumor is located close to sensitive tissues.

An Option for Selected Patients at Higher Surgical Risk

For some patients who are not good candidates for conventional surgery because of age, medical conditions, or tumor location, cryoablation may provide an alternative local treatment option.

Possibility of Repeat Treatment

In selected circumstances, cryoablation can potentially be repeated if residual or recurrent local disease is detected.

Whether repeat treatment is appropriate depends on the tumor location, previous treatment area, surrounding anatomy, and the patient’s overall condition.

Cryoablation vs. Radiofrequency and Microwave Ablation

Cryoablation, radiofrequency ablation, and microwave ablation are all minimally invasive tumor ablation techniques, but they use different physical mechanisms to destroy tissue.

Each technique has its own advantages, limitations, and appropriate clinical applications.

There is no single ablation technique that is best for every tumor.

The choice depends on tumor characteristics, anatomical location, proximity to critical structures, patient factors, available technology, and the expertise of the treating team.

Cryoablation vs. Surgical Resection

Surgical resection and cryoablation are different approaches to local tumor treatment.

With surgical resection, the tumor is physically removed from the body, together with surrounding tissue when medically necessary.

With cryoablation, the tumor is treated in place by exposing the targeted tissue to extremely low temperatures.

For certain localized cancers, surgical resection remains an established or preferred treatment.

Cryoablation does not replace surgery in every situation. Instead, it provides an additional local treatment option for appropriately selected patients.

Are There Side Effects or Risks?

Yes.

Although cryoablation is minimally invasive, it can still cause side effects and complications.

The risks depend on the treatment site, tumor size, number and placement of probes, and proximity of the tumor to nearby organs and critical structures.

Potential complications may include:

• Pain or discomfort
• Bleeding
• Infection
• Local swelling or inflammation
• Injury to adjacent organs or tissues
• Nerve injury
• Procedure-related complications
• Pneumothorax or pleural effusion during certain lung procedures
• Urinary or kidney-related complications following certain renal procedures
• Other site-specific complications

In some cases, post-treatment inflammation or swelling may temporarily affect nearby structures.

For these reasons, cryoablation should not be considered a risk-free procedure.

Before treatment, the medical team should carefully evaluate the potential benefits, risks, and alternative treatment options.

Can Cryoablation Cure Cancer?

The answer depends on the type, stage, and characteristics of the cancer.

For selected small and localized tumors, cryoablation may provide effective local tumor control and, in certain clinical settings, may be performed with curative intent.

However, when cancer has spread extensively throughout the body, local cryoablation alone generally cannot treat all sites of disease.

In advanced cancer, cryoablation may sometimes be used to:

• Control a specific localized tumor
• Relieve tumor-related pain
• Reduce local pressure or symptoms
• Treat a problematic metastatic lesion
• Complement systemic cancer treatment

The potential for long-term disease control depends on the cancer type, stage, tumor burden, response to treatment, and other therapies being used.

Can Cryoablation Be Combined With Immunotherapy?

The combination of cryoablation and immunotherapy is an active area of cancer research.

When cryoablation destroys tumor tissue, tumor-associated antigens may be released, and local inflammatory and immune responses may occur.

Researchers are therefore investigating treatment strategies such as:

Cryoablation + Immune Checkpoint Inhibitors

The underlying concept is that local tumor destruction may expose tumor-associated antigens, while immunotherapy may enhance the body’s anti-tumor immune response.

However, the clinical effectiveness of these combinations varies according to cancer type and treatment setting.

This approach remains an area of ongoing research and should not be presented as evidence that cryoablation can independently stimulate a systemic immune response sufficient to eliminate cancer throughout the body.

Who May Be a Candidate for Cryoablation?

Patient selection is an important part of cryoablation treatment.

The medical team may consider:

• Tumor type
• Tumor size
• Number of tumors
• Tumor location
• Disease stage
• Presence or absence of distant metastases
• Relationship between the tumor and nearby blood vessels, bile ducts, bowel, nerves, or other critical structures
• Overall health
• Previous cancer treatments
• Kidney, liver, or other organ function when relevant
• Whether another treatment may provide greater benefit

Cryoablation may be particularly relevant for selected patients with localized tumors.

For patients with advanced disease, it may be considered as part of a broader treatment strategy that also includes systemic therapy.

Cryoablation as Part of Comprehensive Cancer Care

Modern cancer treatment increasingly relies on a multidisciplinary approach.

Depending on the patient’s condition, the treatment team may include:

Surgical Oncologists + Medical Oncologists + Radiation Oncologists + Interventional Radiologists + Radiologists + Pathologists + Other Relevant Specialists

Cryoablation may be incorporated into a broader treatment plan alongside:

Surgery + Cryoablation

Cryoablation + Targeted Therapy

Cryoablation + Immunotherapy

Cryoablation + Chemotherapy

Cryoablation + Radiation Therapy

These combinations are not appropriate for every patient.

The treatment strategy should be individualized according to the cancer type, stage, previous treatments, treatment objectives, overall health, and the available clinical evidence.

Conclusion

Cryoablation is a minimally invasive local treatment that uses extreme cold to destroy targeted tumor tissue.

With image-guided probe placement and controlled freeze–thaw cycles, physicians can create a defined treatment zone around a tumor while attempting to minimize injury to surrounding healthy structures.

Cryoablation may be considered for selected tumors of the kidney, liver, lung, prostate, bone, soft tissue, and other sites.

However, it is not appropriate for every cancer or every patient, and it should not automatically be considered superior to surgery, radiofrequency ablation, microwave ablation, radiation therapy, or systemic treatment.

The most appropriate treatment depends on the tumor type, stage, size, location, relationship to surrounding structures, previous treatments, overall health, and individual treatment goals.

Patients considering cryoablation should undergo a comprehensive clinical and imaging assessment and discuss the potential benefits, risks, alternatives, and expected outcomes with an experienced multidisciplinary cancer care team.